Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record history shows a new revision label from v3.6.3 to v3.6.4. This represents an updated version of the record without altering study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe study record history now includes a new Revision: v3.6.3 entry, representing an updated version of the record; the previous Revision: v3.6.2 appears as an earlier version in the history.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry for v3.6.2 was added to the record history, and the older revision v3.6.0 was removed from the history list.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision v3.6.0 was added to the study record history. An older revision v3.5.5 was removed from the history.SummaryDifference0.6%

- Check62 days agoChange DetectedA new revision entry, Revision: v3.5.5, was added to the study record history, replacing the previous Revision: v3.5.4. This indicates an update to the record's documentation.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry (v3.5.4) is added to the study record history, replacing the previous v3.5.3 to reflect an update in the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.